Prenatal exposure to phenols and benzophenones in relation to markers of male reproductive function in adulthood. 2022

Stine A Holmboe, and Louise Scheutz Henriksen, and Hanne Frederiksen, and Anna-Maria Andersson, and Lærke Priskorn, and Niels Jørgensen, and Anders Juul, and Jorma Toppari, and Niels E Skakkebæk, and Katharina M Main
Department of Growth and Reproduction, Rigshospitalet, Copenhagen, Denmark.

Environmental exposure during fetal life may disrupt testicular development. In humans, a limited number of studies have investigated whether these adverse effects persist into adulthood. Using data from a prospective, population-based birth cohort study, The Copenhagen Mother-Child cohort, the objective was to assess if there is an association between fetal exposure to selected phenols and benzophenones and markers of testicular function in adult men. Pregnant women were recruited in 1997-2001. Their sons were examined clinically at 18-20 years of age, with focus on adult markers of reproductive function (anogenital distance (AGD), semen quality and reproductive hormones). In total, 101 18-20-year-old men were included, whose mothers during pregnancy had a serum sample drawn and analyzed for bisphenol A (BPA) and seven other simple phenols, as well as six benzophenones. To investigate the association between chemical levels (in tertiles, T1-T3) in relation to markers of reproductive function, univariate and multiple linear regression analyses were performed. In fully adjusted analyses, increased levels of luteinizing hormone (LH) were observed with higher fetal exposure to BPA (percentage difference (95%CI)) (T2: 12% (-8%,36%) and T3: 33% (10%,62%), compared to T1) and benzophenone-3 (BP-3) (T2: 21% (-2%,49%), T3: 18% (-4%,45%)), while no clear association was seen to total testosterone (TT). Higher levels of BPA and BP-3 were associated with a lower TT/LH ratio, although only significant for BPA (p-trend=0.01). No associations were seen to AGD or markers of semen quality. In conclusion, high exposure to BPA and BP-3 was associated with a compensated reduced Leydig cell function but no other changes in markers of reproductive health. As maternal levels of BPA and BP-3 were not correlated, separate effects may be at play. Larger studies on long-term reproductive consequences of prenatal exposures are warranted to validate our findings.

UI MeSH Term Description Entries
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D008297 Male Males
D010636 Phenols Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011297 Prenatal Exposure Delayed Effects The consequences of exposing the FETUS in utero to certain factors, such as NUTRITION PHYSIOLOGICAL PHENOMENA; PHYSIOLOGICAL STRESS; DRUGS; RADIATION; and other physical or chemical factors. These consequences are observed later in the offspring after BIRTH. Delayed Effects, Prenatal Exposure,Late Effects, Prenatal Exposure
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001577 Benzophenones Derivatives of benzophenone (with the structural formula phenyl-(C

Related Publications

Stine A Holmboe, and Louise Scheutz Henriksen, and Hanne Frederiksen, and Anna-Maria Andersson, and Lærke Priskorn, and Niels Jørgensen, and Anders Juul, and Jorma Toppari, and Niels E Skakkebæk, and Katharina M Main
January 2016, Environment international,
Stine A Holmboe, and Louise Scheutz Henriksen, and Hanne Frederiksen, and Anna-Maria Andersson, and Lærke Priskorn, and Niels Jørgensen, and Anders Juul, and Jorma Toppari, and Niels E Skakkebæk, and Katharina M Main
May 2022, European journal of epidemiology,
Stine A Holmboe, and Louise Scheutz Henriksen, and Hanne Frederiksen, and Anna-Maria Andersson, and Lærke Priskorn, and Niels Jørgensen, and Anders Juul, and Jorma Toppari, and Niels E Skakkebæk, and Katharina M Main
January 2013, PloS one,
Stine A Holmboe, and Louise Scheutz Henriksen, and Hanne Frederiksen, and Anna-Maria Andersson, and Lærke Priskorn, and Niels Jørgensen, and Anders Juul, and Jorma Toppari, and Niels E Skakkebæk, and Katharina M Main
June 2012, Current opinion in endocrinology, diabetes, and obesity,
Stine A Holmboe, and Louise Scheutz Henriksen, and Hanne Frederiksen, and Anna-Maria Andersson, and Lærke Priskorn, and Niels Jørgensen, and Anders Juul, and Jorma Toppari, and Niels E Skakkebæk, and Katharina M Main
January 2020, Frontiers in endocrinology,
Stine A Holmboe, and Louise Scheutz Henriksen, and Hanne Frederiksen, and Anna-Maria Andersson, and Lærke Priskorn, and Niels Jørgensen, and Anders Juul, and Jorma Toppari, and Niels E Skakkebæk, and Katharina M Main
May 2014, Environmental toxicology,
Stine A Holmboe, and Louise Scheutz Henriksen, and Hanne Frederiksen, and Anna-Maria Andersson, and Lærke Priskorn, and Niels Jørgensen, and Anders Juul, and Jorma Toppari, and Niels E Skakkebæk, and Katharina M Main
October 2022, Environmental health perspectives,
Stine A Holmboe, and Louise Scheutz Henriksen, and Hanne Frederiksen, and Anna-Maria Andersson, and Lærke Priskorn, and Niels Jørgensen, and Anders Juul, and Jorma Toppari, and Niels E Skakkebæk, and Katharina M Main
February 1995, Bulletin of environmental contamination and toxicology,
Stine A Holmboe, and Louise Scheutz Henriksen, and Hanne Frederiksen, and Anna-Maria Andersson, and Lærke Priskorn, and Niels Jørgensen, and Anders Juul, and Jorma Toppari, and Niels E Skakkebæk, and Katharina M Main
January 1980, Pediatric pharmacology (New York, N.Y.),
Stine A Holmboe, and Louise Scheutz Henriksen, and Hanne Frederiksen, and Anna-Maria Andersson, and Lærke Priskorn, and Niels Jørgensen, and Anders Juul, and Jorma Toppari, and Niels E Skakkebæk, and Katharina M Main
September 2014, Epidemiology (Cambridge, Mass.),
Copied contents to your clipboard!